Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Geelong
Clinical trial register · Australia

Clinical Trials in Geelong, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3343 matching records held by the registry are in this view. Synced 15 Oct 2026, 03:18 UTC
3343
Studies in scope
all four open statuses
1804
Recruiting now
open to new participants
765
Lead sponsors
across recruiting studies
Top sites
Melbourne 25 Brisbane 22 Adelaide 22 Box Hill 16 Westmead 11
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Eli Lilly and Company10 GlaxoSmithKline5 Hoffmann-La Roche4 Pfizer4 Regeneron Pharmaceuticals3 Clear sponsor filter
Site location
Melbourne25 Brisbane22 Adelaide22 Box Hill16 Westmead11
All 95 locations
Target enrolment
to

Trials with a site in Geelong

10 of 3343 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Recruiting
Eli Lilly and Company
Phase 3
1,000
Brisbane, Bruce, Carlton, Elizabeth Vale, Geelong, Melbourne, Toowoomba, Westmead
2026-08-14
Recruiting
Eli Lilly and Company
Phase 3
900
Botany, Box Hill, Brisbane, Camberwell, Geelong, Heidelberg West, Merewether, Oaklands Park
2026-02-10
Recruiting
Eli Lilly and Company
Phase 3
1,000
Carlton, Elizabeth Vale, Geelong, Melbourne, Toowoomba, Westmead
2026-02-09
Recruiting
Eli Lilly and Company
Phase 3
1,205
Box Hill, Brisbane, Canberra, Geelong, Meadowbrook, Perth, Southport, St Leonards
2025-10-31
Recruiting
Eli Lilly and Company
Phase 3
4,500
Adelaide, Box Hill, Brisbane, Broadmeadow, Geelong, Heidelberg, Ipswich, Murdoch
2025-10-15
Recruiting
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
NCT07157774Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD)
Eli Lilly and Company
Phase 3
10,450
Adelaide, Box Hill, Brisbane, Burwood, Clayton, Frankston, Geelong, Greenfields
2025-09-02
Active, closed
Eli Lilly and Company
Phase 3
10,000
Adelaide, Botany, Box Hill, Brisbane, Brookvale, Camberwell, Garran, Geelong
2024-04-30
Active, closed
Eli Lilly and Company
Phase 3
15,374
Adelaide, Blacktown, Box Hill, Brisbane, Camberwell, Clayton, Deakin, Geelong
2022-10-11
Active, closed
Eli Lilly and Company
Phase 3
8,000
Ballarat Central, Box Hill, Clayton, Coffs Harbour, Darlinghurst, Geelong, Hobart, Launceston
2022-10-04
Active, closed
Eli Lilly and Company
Phase 3
493
Camperdown, Sydney, Wahroonga, South Brisbane, Woolloongabba, Woodville, Geelong, Murdoch
2014-11-06
Rows per page Showing 1–10 of 10
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 15 October 2026. https://priyalifescience.com/clinical-trials-australia/city/geelong

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,343 studies in total at the last sync on 15 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 10 of those studies with a site in Geelong that also match the filters currently applied.

How many clinical trials are recruiting in Geelong?

6 of the 10 studies on this page are recruiting new participants as of the 15 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 4 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Geelong), 10 studies
PhaseStudiesRecruitingShare
Phase 3106100%

Most active sponsors

Lead sponsors with the most studies (Geelong)
Lead sponsorStudiesRecruiting
Eli Lilly and Company106
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.